Sarcomas that exhibit the highest percentages of MDM2 amplification include low-grade/periosteal osteosarcoma, atypical liposarcoma/lipomatous tumor, dedifferentiated liposarcoma, and intimal sarcoma [7,8,9,50]. This evidence concerns the gene MDM2 and sarcoma.